Brain sigma receptors labelled by [3H]nemonapride

Area of Science:

• Neuroscience
• Pharmacology
• Receptor Binding Assays

Background:

• Dopamine receptors, particularly D4, are crucial targets in neuroscience.
• Nemonapride and raclopride are radioligands used to study dopamine receptor binding.
• Sigma receptors are a distinct class of receptors with poorly understood functions.

Purpose of the Study:

• To investigate the binding characteristics of [3H]nemonapride and [3H]raclopride in different brain regions across species.
• To determine the influence of sigma receptor ligands on [3H]nemonapride binding.
• To evaluate the specificity of the subtraction method for measuring D4 dopamine receptor binding.

Main Methods:

• Radioligand binding assays were performed using [3H]nemonapride and [3H]raclopride.
• Brain tissue from rats, cows, and humans was utilized.
• Selective sigma receptor ligands and sulpiride were used to differentiate receptor subtypes.

Main Results:

• [3H]nemonapride binding was significantly inhibited by sigma receptor ligands in the frontal cortex, striatum, and cerebellum.
• The striatum exhibited specific dopaminergic binding sites, as confirmed by sulpiride.
• [3H]nemonapride binding demonstrated a component influenced by sigma receptors.

Conclusions:

• The presence of sigma receptors can interfere with the measurement of D4 dopamine receptor binding using the subtraction method ([3H]nemonapride minus [3H]raclopride).
• Researchers should consider the potential sigma receptor contribution when interpreting D4 receptor binding data obtained with this method.
• Further studies are needed to fully elucidate the interaction between nemonapride and sigma receptors in the brain.